Director Svetlana Dey's Stock Acquisition at Bluejay Diagnostics Highlights Shareholder Activity Amid Market Challenges
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) director Svetlana Dey reported acquiring $25,000 worth of the company's common stock on March 14, 2026. This transaction occurred while the stock was trading near its 52-week low and amidst broader corporate activities including a recent private placement by board members and the full exercise of prefunded wa…